Natco Pharma Fires First Shot in Weight-Loss Drug Price War; Generic Semaglutide to Cost 90% Less at ₹1,290 per Month

Ozempic copies for $14 as the generic GLP-1 era starts in India

Indian drugmakers begin selling generic Ozempic copies at $14 monthly Friday — 88% cheaper than Novo's brand-name version.

Eris Lifesciences, Natco Pharma to launch generic Ozempic at 90% cheaper price

Eris launch coincides with a parallel entry by Natco Pharma, which will also bring its semaglutide injections to market on the first day of patent expiry tomorrow

Dozen drugmakers line up Ozempic copies, triggering price crash in India. Generic GLP-1 Era begins

With the patent expiring Friday, Natco Pharma will launch semaglutide shots from ₹1,290/month, with a pen by April at ₹4,500, well below Novo’s Wegovy price of ₹10,480 in India.

Natco Pharma fires first shot in weight-loss drug price war; generic semaglutide to cost 90% less at ₹1,290 per month

With other major players like Sun Pharma and Dr Reddy's also set to launch, the entry of Natco's ₹1,290 per month vial signals a significant shift in affordability.

Natco beats rivals with Rs 1,290 semaglutide launch as Novo Nordisk patent expires

Natco Pharma introduces a new, affordable semaglutide injection in multidose vials. This launch coincides with the patent expiry of the innovator's drug. The company aims to make this treatment more accessible to patients across India. Other pharmaceutical companies are also preparing to launch their generic versions. This development promises significant cost savings for consumers seeking this medication.